SecBot SecBot
PRESS-RELEASE ·Filed Jul 20, 2026

PHAT

Phathom Pharmaceuticals
NEUTRAL
Impact 1/10
Horizonimmediate Processed3mo ago WireGlobeNewswire
Press release · Earnings
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Phathom Pharmaceuticals announced it will report its Q2 2026 results on July 30, 2026.

Key Facts

  • Phathom Pharmaceuticals announced it will report its Q2 2026 results on July 30, 2026.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3329653

US Market Status

Market Closed · Opens in 6h 38m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 20, 2026